BSE Share Price Hits Record High As NSE To Halt Three Weekly Option Contracts
Shares of BSE Ltd. surged nearly 8% to their record high on Friday after rival National Stock Exchange announced the discontinuation of three weekly option contracts.
The NSE announced on Thursday that it will discontinue its weekly index derivatives contracts on Bank Nifty, Nifty Midcap Select, and Nifty Financial Services, effective from Nov. 13, Nov. 18, and Nov. 19, respectively.
The decision aligns with the SEBI directive from Oct. 1, which restricts weekly option expiries to one per exchange starting from Nov. 20. The market regulator's decision aims to regulate the futures and options trading segment.
On Oct. 3, BSE announced the discontinuation of weekly index derivatives contracts on Sensex 50 and Bankex from Nov. 14 and Nov. 18, respectively.
This means that weekly expiry derivatives contracts will continue only on the frontline indices of BSE Sensex and NSE Nifty 50.
The changes, which will come into effect next month, will provide an opportunity for BSE to compete against NSE on more days in the week, analysts at Motilal Oswal Financial Services Ltd. said in a recent report. Currently, the NSE held an edge with expiry derivatives contracts on all days except Friday.
For BSE, since large volumes were happening on expiry day, its premium to notional turnover ratio was at 0.07% against 0.16% for NSE, MOSFL stated in the report, citing the data available for September 2024.
"With the probability of volumes increasing farther than expiry days, this ratio would increase for BSE. This will not only help in revenues but also in bringing down the clearing and settlement costs," it added.
BSE share price spiked to its highest-ever in the final hour of trading.
Shares of BSE closed 7.54% higher at Rs 4,534 apiece on the NSE, compared to a 0.14% decline in the Nifty 50. The stock is up 102.4% on a year-to-date basis and by 203.4% over the past 12 months. The stock surged 7.92% to hit a record high of Rs 4,550 apiece.
Four out of seven analysts tracking BSE have a "buy" rating on its stock, two suggest a "hold," and one recommends a "sell," as per Bloomberg data. The average of 12-month analysts' price target implies a potential downside of 24.3%.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
